Statins
Sort by:
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,193 views
- August 31, 2023
- 10
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
FEATURING
Salim Virani
- 1,174 views
- July 23, 2022
- 13
National Lipid Association
Pearls from 34 Years of Running a Lipid Clinic
FEATURING
Alan Brown
- 1,161 views
- March 25, 2019
- 11
The Texas Heart Institute
The Use of Coronary Artery Calcium Score to Determine Benefit of Aspirin Therapy
FEATURING
Eduardo Hernandez
- 1,144 views
- November 12, 2021
- 11
National Lipid Association
ACC/AHA Cholesterol Guideline: How to Handle the High-Risk Patients
FEATURING
Kim Birtcher
- 1,103 views
- March 25, 2019
- 6
The Texas Heart Institute
Triglyceride Lowering Therapies: What Have We Recently Learned? What Is Coming Down the Pipeline?
FEATURING
Salim Virani
- 1,096 views
- April 22, 2021
- 6
Advances in Cardiovascular Disease Prevention
Can Lifestyle Changes Reverse Type 2 Diabetes?
FEATURING
Dean Ornish
- 1,059 views
- October 22, 2018
- 3
Cardiometabolic Health Congress (CMHC)
Non-Statin Drugs and New Approaches
FEATURING
Marc Sabatine,
Christie Ballantyne
- 1,028 views
- January 10, 2019
- 6
Keck School of Medicine of USC
Role of Lipoprotein(a) in Coronary Disease: What CV Risks Can you Expect? How to Manage the Condition?
FEATURING
Steven Nissen
- 947 views
- January 5, 2021
- 13
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 924 views
- February 5, 2021
- 11
The Texas Heart Institute
Updates in Guidelines for the Management of Chronic Coronary Artery Disease: What We Should Pay Closer Attention To
FEATURING
Salim Virani
- 913 views
- March 15, 2024
- 10
National Lipid Association
Pediatric Lipidology - Is There a Need for More Training and Availability of Clinical Services
FEATURING
Adam Ware
- 911 views
- March 25, 2019
- 6
Cardiometabolic Health Congress (CMHC)
2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?
FEATURING
Salim Virani
- 896 views
- September 22, 2020
- 3
Michigan Medicine
Statin Hepatotoxicity: Recognition and Management
FEATURING
Robert Fontana
- 868 views
- January 12, 2024
- 4
National Lipid Association
Bempedoic Acid: Mechanism of Action, Effects and Potential Uses
FEATURING
Anne Goldberg
- 842 views
- March 19, 2020
- 3
MUSC Cardiology
Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients
FEATURING
Pamela B. Morris
- 838 views
- March 29, 2024
- 8
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 834 views
- August 10, 2018
- 10
Cardiovascular Disease Management - 5th Annual Symposium
Statins are Way Underused… and it’s Killing Americans
FEATURING
Dinesh Kalra
- 829 views
- December 27, 2017
- 6
